CYTK Cytokinetics, Incorporated
Healthcare$76.29-0.84%ClosedMarket Cap: $9.49B
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
16
Dispositions
26
Buy/Sell Ratio
0.62
Net Shares
-141,489
Shares Acquired
82,310
Shares Disposed
223,799
Total Bought ($)
$0.00
Total Sold ($)
$16.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed May 20 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $75.69 | 153,902 |
| Wed May 20 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $7.80 | 157,402 |
| Thu May 14 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $77.92 | 400,330 |
| Tue May 05 | WIERENGA WENDELL | director | Sell | 4,032 | $75.00 | 32,637 |
| Tue May 05 | WIERENGA WENDELL | director | Sell | 4,032 | $12.40 | 36,669 |
| Tue May 05 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $77.37 | 153,902 |
| Tue May 05 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $7.80 | 157,402 |
| Tue May 05 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 23,906 | $76.87 | 63,221 |
| Tue May 05 | HENDERSON JOHN T | director | Sell | 20,000 | $75.97 | 75,237 |
| Tue May 05 | HENDERSON JOHN T | director | Sell | 20,000 | $7.61 | 95,237 |
| Thu Apr 30 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,000 | $63.26 | 58,555 |
| Thu Apr 30 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,000 | $23.26 | 73,555 |
| Wed Apr 29 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $59.62 | 407,830 |
| Tue Apr 21 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $65.69 | 153,902 |
| Tue Apr 21 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $7.80 | 157,402 |